Ventral Hernia Mesh Devices Market Size & Trends
The size of the ventral hernia mesh devices market was estimated at USD 839.5 million in 2024 and is expected to grow at a CAGR of 8.48% during the period 2025-2030. The rising incidence of hernias, advancements in mesh repair technology, a trend towards preventive care, and an increasing demand for minimally invasive surgeries are the drivers of the market's growth.
There is an increasing number of skin cancer patients worldwide, propelling the demand for better technology to support enhanced cancer care. The U.S. FDA says that more than a million hernia repair operations are carried out every year in the U.S.
Repair of hernia is among the most frequent operations worldwide. The rate of occurrence of hernia in men is more than that of women. According to Verywell Health, approximately 20% of adults will develop a primary ventral hernia, which is expected to rise to about 30% following surgery. This disorder is associated with risk factors such as obesity, smoking, unhealthy lifestyle, and age. About 75% of all hernias occur in the groin in adults each year, leading to an increase in the adoption of hernia repair devices. The large prevalence of hernia is driving the demand for effective hernia repair, which is anticipated to propel the market growth.
The International Surgery Journal further indicates that incisional and para-umbilical hernias account for 85% of all ventral hernias. Additionally, umbilical hernias occur more in men (65%) compared to women (35%), mainly due to the fact that congenital umbilical hernias are not as common among women.
As the world's population ages, more individuals at greater risk for hernias are present. This resulted in an increase in reported cases, even though the true incidence per capita is not changing. Improved medical imaging, such as ultrasounds and CT scans, allows for easier and more frequent detection of hernias, even asymptomatic ones. This creates an illusion of greater prevalence as the former undiagnosed cases are now being recognized. There are also lifestyle factors that enhance the risk of having a hernia. These are obesity, persistent cough, and lifting heavy objects. Besides that, public awareness campaigns and access to easy information about medical topics make individuals aware of the hernia and symptoms. This resulted in increased vaginal discharge and more individuals seeking treatment and getting diagnosed, thus resulting in a perceived increase in cases.
This increased incidence of hernia worldwide and enhanced patient outcomes through the application of meshes, which decrease operative and convalescent time, are some benefits likely to drive market growth. Some uses of vaginal meshes include the relief of pain and vaginal tightening, with reducing recurrence chances being another benefit of employing them. For example, as per statistics released by Northeast Georgia Health System, the application of mesh in hernioplasty can decrease the risk of recurrence by as much as 50%. In America, mesh use is the common standard in ventral, incisional, and inguinal hernia repair.
Moreover, mesh repair devices are elastic and possess a flexible shape that is congruent to the dynamic change of the abdominal walls. The porous mesh enables lower foreign body reaction and improved & quicker soft tissue ingrowth, leading to flexible scar formation. Therefore, all these advantages of mesh use in hernia surgery are expected to drive the growth of the market.
Mesh can be applied to open as well as laparoscopic surgery. Laparoscopic surgeries involving mesh provide quicker recovery, minimal pain, and smaller cuts compared to conventional open repairs without mesh, thus fueling market demand for hernia mesh devices.
Advancements in technology of hernia mesh devices have contributed significantly to improved patient recovery and fewer complications. Such an important innovation is the introduction of lightweight and composite meshes. These meshes, like Parietex Composite Mesh, are made of both absorbable and non-absorbable materials, which give strength while minimizing postoperative pain and the likelihood of chronic pain. For example, in March 2024, Deep Blue Medical Advances, Inc. launched the T-Line Hernia Mesh, which prevents recurrence of hernias following abdominal hernia repair surgery.
Market Concentration & Characteristics
The ventral hernia mesh devices market exhibits moderate industry concentration, with several key players dominating the market. Initiatives to raise awareness and knowledge about ventral hernia conditions and early diagnosis further stimulate market growth. The ventral hernia mesh devices industry is characterized by high innovation. Notable innovations have included advancements in materials, design, and surgical techniques. Major advances are the production of biocompatible materials, including absorbable meshes, that minimize long-term foreign body reactions while supplying necessary support throughout healing; research has demonstrated these can produce reduced rates of chronic pain and recurrence. Furthermore, self-fixating meshes using micro-grip technology, including the Symbotex mesh, improve the efficiency of surgery by not requiring sutures or adhesives, minimizing operative time and complications. Regulatory systems play an important role in the ventral hernia mesh devices industry since the products are categorized under medical devices in the majority of geographies.
Obtaining compliance with regulatory conditions, for instance, US FDA regulations or EU CE marking, is critical in order to penetrate the market and gain customer confidence. Regulations touch upon many elements, for instance, product design, production procedures, and post-market monitoring, affecting product development timelines and access to markets. Developing regulatory environments call for ongoing oversight and adjustment on the part of industry participants to maintain compliance and effectively navigate market conditions. Ventral hernia mesh devices mergers and acquisitions are increasing because the industry is dynamic and requires research and development, hence driving mergers and acquisitions. Firms acquire other firms to increase their product portfolio, access new geographies, get access to advanced technologies, and benefit from economies of scale. Acquisitions here are meant to increase portfolios, get access to AI capabilities, or enter new geographies.
The market for ventral hernia mesh devices competes against traditional and advanced imaging technologies. The use of traditional mesh repair devices continues as it is relatively cost-effective and less complex to execute. Another alternative offered to compete is in laparoscopic approaches where sutures replace the use of mesh in particular cases of hernia repair. Research and developments within tissue engineering and regenerative medicine are promoting innovations to produce injectable biomaterials that encourage healing and regrowth of tissues without the need for permanent devices.
The global ventral hernia mesh devices market is growing, with Europe and North America at the forefront of adoption thanks to sophisticated healthcare infrastructure, better awareness, and regulatory certainty.
The Asia-Pacific region is growing fast, particularly in urban China, Japan, South Korea, and India, with improving access to healthcare, increasing rates of hernia, and greater availability of laparoscopic and robotic platforms for hernia fixation. For example, in April 2024, TELA Bio, Inc. introduced its OviTex IHR surgical mesh for inguinal hernia repair in the U.S. The new product combines biologic and synthetic materials, with the goal of improving patient outcomes by offering a durable & flexible repair option, which may minimize complications and hasten recovery times for patients undergoing hernia surgery.
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Mesh Type Insights
The non-resorbable mesh devices market held the maximum market share of 47.20% in 2024. The high market share is due to its proven clinical effectiveness, cost, and good surgeon acceptance. These meshes, made of materials like polypropylene or expanded polytetrafluoroethylene (ePTFE), offer permanent mechanical support with a significant reduction in recurrence rates compared to the resorbable counterparts. For instance, a retrospective analysis published in Surgical Endoscopy revealed that the application of synthetic mesh for ventral hernia repair was associated with a recurrence rate of just 13%, compared with 20% for biologic mesh. Additionally, non-resorbable mesh is less expensive and more generally reimbursed by healthcare systems, and hence, a cost-effective choice for public and private sectors alike.
The resorbable mesh segment is anticipated to expand at the highest CAGR of 11.4% during the forecast period. Resorbable meshes are surgical devices employed in ventral hernia repair that are completely degraded and absorbed by the body over time. The growth in the market is fueled by increasing preference in high-risk and contaminated procedures, improvement in biomaterials and their performance, decline in long-term capabilities, and growing application in outpatient facilities and minimally invasive procedures.
Indication Insights
In 2024, incisional hernia segment held the largest market share, 43.40%, of the ventral hernia mesh devices market. Incisional hernia is the second most frequent type of hernia after inguinal hernia. Incisional hernia occupies 10% of all abdominal wall incisions. It is more prevalent in women, as the majority of women have midline abdominal surgery while giving birth. Risk factors for incisional hernia are obesity, smoking, intraoperative surgical site infections, wound healing disturbances, malnutrition, and connective tissue disorders. The rate of recurrence following the initial surgical operation for incisional hernia varies from 25% to 52%. The American College of Surgeons reports that recurrence in open incisional hernia repairs using mesh is less than in those using sutures. Laparoscopy with a mesh has a recurrence rate of as little as 3.4%. Therefore, mesh repair is used for incisional hernias.
Umbilical hernia segment is anticipated to increase considerably during the forecast period. This growth is driven by the rising incidence of umbilical hernia, especially among the aging population. Umbilical hernias are caused by a weakness in the abdominal wall between the stomach and chest. Umbilical hernias are not very prevalent, leading to fewer repairs done for the cure of umbilical hernias.
Procedure Insights
The open surgery segment held the maximum ventral hernia mesh devices market share in 2024. Market growth is affected by the occurrence of intricate and comparatively large hernias, extensive surgical training and facilities, surgeons' high preference for open surgeries, less equipment and setup needs, and cost-effectiveness in low- and middle-income economies. Open procedures can also accommodate larger or more complex mesh placements, such as advanced methods like component separation, which are not as easily accomplished with minimally invasive techniques. As much as minimally invasive methods are developing, open surgery still dominates the volume of procedures due to its ease and efficacy in many clinical conditions.
The robotic surgery segment is anticipated to develop rapidly over the forecast period. This expansion is driven by the capability to increase surgical accuracy, lower the risk of complications, and enhance recovery periods. The robot technology provides improved visualization, dexterity, and control, enabling surgeons to achieve intricate hernia repair, such as TAR or component separation, with high precision and minimal invasiveness. For instance, research in Surgical Endoscopy and Annals of Surgery has shown that robotic ventral hernia repair is linked with decreased conversion rates, shorter hospital stays, and less postoperative pain than open or traditional laparoscopic approaches. Moreover, the growing accessibility of robotic systems and continuous surgeon training programs are driving adoption worldwide, especially in high-volume and tertiary care facilities.
End Use Insights
The inpatient facilities segment held 50.6% of the market for ventral hernia mesh devices. Hospital inpatient facilities are critical players in the market for hernia mesh devices, acting as central sites for hernia repair procedures. They create demand for hernia mesh products and drive market trends by embracing innovative surgical methods and technology. Hospitals and clinics also drive market growth through involvement in clinical trials and research studies, driving innovation in hernia mesh technology. For example, as per Springer Nature data released in April 2024, the FDA works with hospitals through initiatives like MedSun and the Medical Device Innovation Consortium (MDIC) to improve postmarket monitoring of hernia mesh devices. MedSun, covering 350 hospitals, supports bi-directional communication between the FDA and hospitals to enable active detection and clearance of potential issues with devices. The outpatient facilities market will expand considerably during the forecast period.
Outpatient facilities like ambulatory surgical centers offer same-day surgical treatment, such as diagnostic and preventive tests. They are well-liked for being economical, convenient, and having fewer chances of infections when compared with regular hospitals. Increasing demand for laparoscopic procedures, which have quicker recovery and less pain post-surgery, is consistent with the strengths of ASCs. The trend is fueled by new surgical technology and better hernia mesh products, leading to safer and more effective surgery.
Regional Insights
The North American ventral hernia mesh devices market led the global market and held a revenue share of 50.9% in 2024. The growth drivers include the rise in incidence and recurrence of hernia, the growing awareness towards early detection of disease and its treatment, and the presence of sophisticated technologies and imaging modalities that enhance the physician's capabilities to diagnose and treat these disorders. Also, patients are increasingly demanding non-invasive diagnostic tests, which provide in-depth evaluations without the pain involved with conventional hernia repair.
U.S. Ventral Hernia Mesh Devices Market Trends
The U.S. ventral hernia mesh devices market captured a large share of North America's ventral hernia mesh devices market in 2024, led by increasing cases of ventral hernia and technology improvements. Repair of hernias is prevalent in the nation, and approximately 1 million hernia repairs are carried out each year in the United States, according to the American Society of Anesthesiologists. Hernias are highly prone to recurrence, and surgeons perform surgical mesh to reinforce hernia repair and limit the rate of recurrence. Prevalence of inguinal hernia is the highest with nearly 800,000 procedures carried out annually. The availability of strong reimbursement scenarios for hernia mesh is motivating patients to undergo surgery. Patients can access detailed reimbursement codes & ratios easily from the government and industry participants.
Europe Ventral Hernia Mesh Devices Market Trends
The European ventral hernia mesh devices market is growing due to rising incidence of chronic diseases, advancements in technology, and regulatory support for new imaging systems. In June 2024, the EU wants to harmonize reporting of adverse effects from surgical mesh implants in member states. Reports of serious complications of surgical mesh for pelvic conditions over the last decade have prompted the EU to act. Regions like Germany, France, and the UK are leading this growth, with robust healthcare infrastructure and positive reimbursement policies driving the use of ventral hernia mesh devices and minimizing reliance on healthcare centers.
The UK market for ventral hernia mesh devices is among the most prominent markets in the region. The increasing prevalence of hernia has raised the demand for hernia mesh repair. In addition, technological progress and the changing dynamics in healthcare propel the market. Technology plays a central role in propelling the growth of the UK ventral hernia mesh devices market, with increasing focus on innovation in mesh materials, techniques, and minimally invasive platforms. For instance, devices such as the Phasix Mesh and Ventralight ST have found popularity among UK surgical facilities as a result of their excellent biocompatibility and ease of use in laparoscopic and robotic surgeries.
The French ventral hernia mesh devices market is likely to expand during the forecast period. The rapidly increasing population and high proportion of the elderly make it one of the EU's fastest-aging nations. France's population demographics are rapidly transforming, with 26% of its population above the age of 60, or one in four inhabitants, as per an article by Béatrice Madeline in March 2023. France's strong healthcare system and focus on early diagnosis have created a suitable setting for the acceptance of cutting-edge imaging technology.
France has seen a steady rise in robotic-assisted hernia repairs, with institutions like Hôpital Européen Georges-Pompidou in Paris integrating da Vinci robotic systems for complex abdominal wall reconstructions. These technologies enable surgeons to perform intricate procedures with higher precision and lower conversion rates than traditional methods. France is also at the forefront of utilizing digital preoperative planning and 3D modeling tools to tailor mesh size and placement, which enhances surgical accuracy and reduces recurrence.
The Germany ventral hernia mesh devices market will grow extensively during the forecast period. Germany's ventral hernia mesh devices market is growing strongly because of the rise in technology and a high incidence of ventral hernias. Hernia societies in the nation are dedicated to ensuring quality care for hernia patients because of the intricate nature of surgeries. The German Hernia Society and German Society for General & Visceral Surgery qualified several hernia centers in Germany. There are more than 1,200 hospitals with a general surgery department and 82 qualified hernia centers in Germany. There are two to three qualified hernia surgeons in every center.
The Italian ventral hernia mesh devices market is expected to grow during the forecast period owing to the growing demand for complex surgical procedures for every kind of hernia, including resorbable and partially absorbable meshes. In addition, the growth in the number of minimally invasive surgeries is among the key factors driving market growth, as it drives demand for specialized hernia mesh devices that are acceptable for laparoscopic surgeries. In addition, the Italian Society of Hernia and Abdominal Wall Surgery (ISHAWS) has established criteria for certified hernia centers to guarantee attention to better quality for patients.
Asia Pacific Ventral Hernia Mesh Devices Market Trends
The ventral hernia mesh devices market in the Asia Pacific region is projected to experience the fastest growth during the forecast period. China and Japan are expected to dominate this market, and India is also expected to grow. Additionally, the availability of trained professionals and the development of healthcare facilities are anticipated to contribute significantly to market growth. Furthermore, the increasing disposable income of people in Asia is expected to increase the demand for ventral hernia mesh devices.
The Japan ventral hernia mesh devices market will expand in the forecast period. Japan's well-developed healthcare infrastructure and advanced surgical tool availability have expanded the market. Furthermore, a rising incidence of hernias, increasing healthcare expenditures, and advancements in surgical techniques have expanded the market. The region is witnessing a significant surge in surgical procedures, with the World Health Organization estimating that over 2.5 million hernia repairs are performed annually across Asia-Pacific countries. In addition, the Japanese government is taking measures to promote the healthcare industry, which is expected to contribute to market growth. The low prevalence of obesity in Japan minimizes the risk of hernia. However, Westernization has contributed to changing food habits, which is leading to an increase in the prevalence of hernia in the younger population.
The China ventral hernia mesh devices market is expected to grow over the forecast period. A growing aging population, increasing surgical volumes, and rising healthcare infrastructure drive the market in China. China has a substantial number of elderly individuals, with projections indicating that by 2030, over 300 million people are expected to be aged 60 and older, significantly raising the incidence of hernias. For instance, according to the Chinese Medical Association, the country sees approximately 1.5 million hernia repair surgeries annually, which is expected to rise as awareness of treatment options increases.
Latin America Ventral Hernia Mesh Devices Trends
The hernia mesh devices market in Latin America is driven by several key factors, including a rising prevalence of hernias, advancements in surgical technology, and increased healthcare investments across the region. With a population exceeding 650 million, Latin America is experiencing significant demographic changes, including an aging population more susceptible to hernias. The Pan American Health Organization estimates that hernia repairs account for a substantial portion of surgical procedures in the region, with hundreds of thousands of cases reported annually.
Middle East & Africa Ventral Hernia Mesh Devices Trends
An aging population and increasing lifestyle risk factors, such as obesity, contribute to a growing number of hernia cases in the MEA region. Advancements in diagnostic tools and techniques have led to earlier detection of hernias, prompting more patients to seek treatment. Public health initiatives and rising disposable income are increasing awareness of hernia repair procedures using mesh, making them a more considered option.
The ventral hernia mesh devices industry in Saudi Arabia is anticipated to expand in the forecast period. The factors affecting market growth include advancements in medical technology and the rising prevalence of hernia types, such as umbilical and epigastric hernias. Saudi Arabia has the region's largest number of hospitals and primary healthcare centers. Moreover, increased disposable income due to economic growth and urbanization is anticipated to create lucrative growth opportunities. The Saudi Arabian government is diverting funds toward developing a robust healthcare infrastructure by establishing new hospitals. For instance, the Ministry of Health was expected to spend approximately USD 71 billion over 5 years ending in 2020, which aligns with the government’s Vision 2030 and the National Transformation Program.
Key Ventral Hernia Mesh Devices Company Insights
The ventral hernia mesh devices market is highly competitive. Key players such as Medtronic plc, Ethicon Inc., Becton, Dickinson and Company, Novus Scientific AB, and B. Braun SE hold significant positions. Leading companies are pursuing a mix of organic and inorganic strategies, including new product development, partnerships, acquisitions, mergers, and regional growth, to address the unmet demands of their customers.
Key Ventral Hernia Mesh Devices Companies
The following are the leading companies in the ventral hernia mesh devices market. These companies collectively hold the largest market share and dictate industry trends.
- Medtronic plc
- Becton, Dickinson and Company (BD)
- Ethicon Inc. (Johnson & Johnson MedTech)
- Meril Life Sciences Pvt. Ltd.
- Novus Scientific AB
- B. Braun SE
- TELA Bio, Inc.
- BG Medical LLC
- Integra LifeSciences Corporation
- W. L. Gore & Associates, Inc.
- Atrium Medical
Recent Developments
-
In April 2025, BD (Becton, Dickinson and Company) gained FDA 510(k) clearance and launched the Phasix ST Umbilical Hernia Patch, a completely absorbable mesh that is specifically designed for repair of umbilical hernia.
During February of 2024, RTI Surgical, Inc. acquired Cook Group Incorporated to augment its prowess in surgical and regenerative medicine. The acquisition allowed RTI to expand its range of biologic and synthetic products, particularly in hernia repair and wound management, hence enhancing its ability to provide groundbreaking surgical solutions.
In June 2023, Advanced Medical Solutions Limited gained FDA approval for its LiquiFix FIX8 and Precision Hernia Mesh Fixation Devices. These devices use a liquid adhesive to fixate mesh in laparoscopic and open hernia repairs, providing more fixation points and possibly less pain than conventional tacks.
Ventral Hernia Mesh Devices Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 902.7 million |
|
Revenue forecast in 2030 |
USD 1,356 million |
|
Growth rate |
CAGR of 8.48% from 2025 to 2030 |
|
Actual data |
2018 - 2024 |
|
Forecast period |
2025 - 2030 |
|
Quantitative units |
Revenue in USD million/billion, and CAGR from 2025 to 2030 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Mesh type, indication, procedure, end use, region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, and MEA |
|
Country scope |
U.S.; Canada, Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
Medtronic plc; Ethicon Inc. (Johnson & Johnson MedTech); Meril Life Sciences Pvt. Ltd.; Becton, Dickinson and Company; Novus Scientific AB; B. Braun SE; TELA Bio, Inc.; BG Medical LLC; Integra LifeSciences Corporation; W. L. Gore & Associates, Inc.; Atrium Medical |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Global Ventral Hernia Mesh Devices Market Report Segmentation
Mesh Type Outlook (Revenue, USD Million, 2018 - 2030)
-
-
Resorbable Mesh
-
Partially Absorbable Mesh
-
Non-resorbable Mesh
-
-
Indication Outlook (Revenue, USD Million, 2018 - 2030)
-
Umbilical Hernia
-
Epigastric Hernia
-
Incisional Hernia
-
Others
-
-
Procedure Outlook (Revenue, USD Million, 2018 - 2030)
-
Open Surgery
-
Laparoscopic Surgery
-
Robotic Surgery
-
Others
-
-
End Use Outlook (Revenue, USD Million, 2018 - 2030)
-
Inpatient Facilities
-
Outpatient Facilities
-
-
Region Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy